Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 374-378, February 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ip, C.
Right arrow Articles by Bernardis, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ip, C.
Right arrow Articles by Bernardis, L. L.

Role of Prolactin in the Promotion of Dimethylbenz[a]anthracene-induced Mammary Tumors by Dietary Fat1

Clement Ip2, Philip Yip and Lee L. Bernardis

Department of Breast Surgery and Breast Cancer Research Unit, Roswell Park Memorial Institute, Buffalo 14263, [C. I., P. Y.], and Division of Endocrinology, Veterans Administration Medical Center, Buffalo, New York 14215 [L. L. B.]

Following 7,12-dimethylbenz[a]anthracene (DMBA) administration, increased tumor incidence and tumor yield were observed in intact rats fed a 20% corn oil diet compared to those fed a 0.5% corn oil diet. Elevated serum prolactin levels (determined at proestrus) were also found in the former group of animals. In order to delineate whether this was responsible for the promoting effect of dietary fat in DMBA-induced mammary carcinogenesis, rats fed these two diets were subjected to electrolytic lesion of the median eminence that resulted in higher circulating prolactin concentrations. Sham-operated animals were used as controls. Results showed that this endocrine manipulation increased the tumor incidence in the low-fat group nearly 3-fold, but it failed to elicit further enhancement in the high-fat rats. Although the serum prolactin level in the low-fat-lesioned rats was comparable to that in the high-fat-lesioned rats, the tumor incidence in the former group still lagged behind that in the latter (33.3 versus 70.4%). Thus, it can be concluded that, although increased circulating prolactin in rats fed the high-fat diet may be partly responsible for the higher tumor incidence, other factors besides prolactin may be involved in the promoting effect of dietary fat in mammary carcinogenesis.

1 This work was supported in part by Grant CA 14812-05 from the National Cancer Institute, NIH and by Grant 76-84381 from the National Science Foundation.

2 Recipient of an award from the Biomedical Research Support Grant, Roswell Park Memorial Institute, in partial support of this work. To whom requests for reprints should be addressed, at Roswell Park Memorial Institute, 666 Elm Street, Buffalo, N. Y. 14263.

Received 8/17/79. Accepted 11/ 1/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.